About Index Trending news
Analyze
Pricing
SV Life Sciences

SV Life Sciences

Work at SV Life Sciences? Add yourself to this profile

SV Life Sciences

Life Sciences Venture Capital firm focused on selectively investing in biotech, medical devices and health-care services.

Elsewhere

Alexa global traffic share

Twitter followers

20 Mar 2017
$30,000,000
Venture capital (Series B)
SV Life Sciences, F-Prime Capital Partners, Johnson & Johnson, +2

British biotech Pulmocide raises £24m in bid to find treatment for deadly lung diseases

The Telegraph
+1
04 Jan 2017
$8,000,000
Venture capital (Series A)

Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics

prnewswire
+1
21 Sep 2016
01 Aug 2016
$11,890,000
Venture capital (Series A)

Aligned TeleHealth takes in $12 mln Series A

PE Hub
+1
14 Jul 2016
$32,000,000
Venture capital (Series C)
SV Life Sciences, Lumira Capital, Aperture Venture Partners, +2

Device startup with a digital health twist raises $32M in series C round

MedCity News
15 Jan 2015
$12,400,000
Venture capital (Series A)
08 Dec 2014
09 May 2014
14 Nov 2013
$32,400,000
Venture capital (Series B)
11 Sep 2013
$11,900,000
Debt financing
SV Life Sciences, Oxford Bioscience Partners, Forward Ventures
06 Feb 2013
03 Apr 2012
02 Apr 2012